Figure 1. Relationship between POLE mutations and patient prognosis in ovarian carcinomas.

In 22 patients with endometrioid and clear cell carcinoma, Kaplan-Meier survival analysis was performed, showing that POLE mutation positivity (blue line; n = 9) and negativity (green line; n = 11) are not associated with progression-free survival and overall survival (P = 0.938, log-rank test; P = 0.391, log-rank test).